Close Menu

RESEARCH TRIANGLE PARK, N.C.--Duke University researcher Allen Roses has been named director of Glaxo Wellcome's $48 million international genetics program. He will be based in the company's U.S. headquarters here and continue working at Duke as an adjunct professor. Previously, Glaxo Wellcome had funded Roses's Alzheimers research.

The Glaxo Wellcome genetics program employs 150 researchers in laboratories in the U.S., the U.K., and Switzerland. The company has said it expects the size of the department to double over the next 18 months.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

IBM security researchers warn of a phishing campaign targeted at organizations involved in the distribution of SARS-CoV-2 vaccines, the Verge reports.

The Illinois police have cut the number of DNA tests waiting to be run in about half, CBS Chicago reports.

A researcher accused of smuggling research materials out of the US has pleaded guilty to making false statements, according to the Associated Press.

In Science this week: gene expression signature linked to nonalcoholic fatty liver disease progression, and more.

Dec
15
Sponsored by
UgenTec

Diverse components of the UC Davis campus have been mobilized to deploy HTP testing to provide a safe working environment and keep the pandemic under control.